<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-39" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Aortofemoral Bypass</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dellehunt</surname>
            <given-names>Rachel E.</given-names>
          </name>
          <aff>Cape Fear Valley Medical Center, CUSOM</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Manna </surname>
            <given-names>Biagio</given-names>
          </name>
          <aff>RWJUH/Barnabas Health System</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rachel Dellehunt declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Biagio Manna declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-39.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Aortofemoral bypass surgery has been used in the management of aortoiliac occlusive disease since the 1950s. Today, revascularization with endovascular intervention has largely replaced aortofemoral bypass surgery and is accepted as first-line therapy. However, in cases where endovascular techniques are not appropriate, aortofemoral bypass continues to have an important role. Practitioners should be familiar with this technique, as it may be a viable option for patients who are not candidates for or have failed revascularization with endovascular intervention. This activity describes the relevant anatomy, indications, and contraindications and reviews important technical considerations of the aortofemoral bypass procedure. This activity highlights the role of the interprofessional team in caring for patients undergoing aortofemoral bypass surgery.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications for aortofemoral bypass surgery.</p></list-item><list-item><p>Review the contraindications for aortofemoral bypass surgery.</p></list-item><list-item><p>Outline the steps involved in performing an aortofemoral bypass surgery.</p></list-item><list-item><p>Explain the importance of interprofessional teamwork in ensuring the appropriate selection of candidates for aortofemoral bypass surgery and in providing effective post-operative management.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=39&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=39">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-39.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Aortofemoral bypass surgery is a procedure utilized&#x000a0;commonly for the treatment of aortoiliac occlusive disease, sometimes referred to as Leriche syndrome.<xref ref-type="bibr" rid="article-39.r1">[1]</xref>&#x000a0;Aortoiliac occlusive disease can contribute to lower extremity ischemic symptoms necessitating intervention. Symptoms of patients with aortoiliac occlusive disease may&#x000a0;include claudication,&#x000a0;rest pain of the lower extremities, or&#x000a0;ischemic ulcer formation on lower extremities due to inadequate blood flow. However, patients may also be asymptomatic. An ankle-brachial index is the most widely used test to determine peripheral arterial disease initially. Aortofemoral bypass surgery has aided in the management of aortoiliac occlusive disease dating back to the early 1950s. More recently, revascularization with endovascular interventions has supplanted the aortofemoral bypass surgery as first-line therapy. However, in cases where endovascular techniques are unsuccessful or inappropriate,&#x000a0;aortobifemoral bypass still plays an important role and can even be considered the gold standard for long term patency.<xref ref-type="bibr" rid="article-39.r2">[2]</xref>&#x000a0;This will discuss the relevant anatomy, indications, contraindications, as well as some important technique considerations.<xref ref-type="bibr" rid="article-39.r3">[3]</xref><xref ref-type="bibr" rid="article-39.r4">[4]</xref><xref ref-type="bibr" rid="article-39.r5">[5]</xref></p>
      </sec>
      <sec id="article-39.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Essential anatomy relevant to the aortofemoral bypass includes the aorta which bifurcates into the&#x000a0;right and left common iliac arteries. The right and left common iliac arteries (CIA) subsequently branch into the&#x000a0;right and left external (EIA) and internal&#x000a0;iliac arteries (IIA). The external iliac arteries&#x000a0;give rise to the common&#x000a0;femoral arteries (CFA). Aortoiliac occlusive disease can occur anywhere along these arteries and vary in degree. It is important to comprehend the anatomical relationship of these structures for the disease process, procedure, and where an anastomosis might occur as well as where clamps would need to be applied.<xref ref-type="bibr" rid="article-39.r2">[2]</xref><xref ref-type="bibr" rid="article-39.r3">[3]</xref><xref ref-type="bibr" rid="article-39.r4">[4]</xref><xref ref-type="bibr" rid="article-39.r6">[6]</xref> The most common mode to visualize these structures is with CT angiography, which can also be used to create 3D reconstructions of the anatomy.<xref ref-type="bibr" rid="article-39.r7">[7]</xref></p>
      </sec>
      <sec id="article-39.s4" sec-type="Indications">
        <title>Indications</title>
        <p>In cases of aortoiliac occlusive disease, classic indications for surgical intervention include the following<xref ref-type="bibr" rid="article-39.r1">[1]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Iliac artery or abdominal aorta severe atherosclerosis causing symptoms&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Acute occlusion of iliac arteries or abdominal aorta</p>
          </list-item>
          <list-item>
            <p>Severe symptoms of claudication despite optimal medical therapy</p>
          </list-item>
          <list-item>
            <p>Gangrene of leg, nonhealing ulcers</p>
          </list-item>
          <list-item>
            <p>Critical limb ischemia, which can present as rest pain or severe claudication symptoms.</p>
          </list-item>
          <list-item>
            <p>Impotence&#x000a0;</p>
          </list-item>
        </list>
        <p>Before the surgical intervention, a trial of smoking cessation, regular exercise, antiplatelet therapy, weight loss, treatment of underlying hyperlipidemia, hypertension, diabetes is in order.<xref ref-type="bibr" rid="article-39.r8">[8]</xref></p>
        <p>A classification system termed the Trans-Atlantic Inter-Society Consensus was created to help clinicians determine if an open or endovascular technique was best suited for patients based on the morphological classification of their lesions.<xref ref-type="bibr" rid="article-39.r9">[9]</xref>&#x000a0;The system provides a means to classify and categorize&#x000a0;atherosclerotic lesions involving the aortoiliac, femoropopliteal, and infrapopliteal regions. It takes into account the extent of stenosis, presence of calcification, as well as laterality, length, and complexity of the lesions. The lesions are classified in categories A-D, as defined below. Typically type A &#x00026; B are&#x000a0;preferably managed endovascularly, whereas&#x000a0;type C (in low-risk patients) and type D classifications are candidates for management with&#x000a0;surgical bypass.<xref ref-type="bibr" rid="article-39.r5">[5]</xref><xref ref-type="bibr" rid="article-39.r6">[6]</xref><xref ref-type="bibr" rid="article-39.r10">[10]</xref><xref ref-type="bibr" rid="article-39.r11">[11]</xref> Although this is true, there are some instances were even Type C and D lesions undergo treatment with endovascular therapy. And patients should all be considered for endovascular therapy before surgery.<xref ref-type="bibr" rid="article-39.r12">[12]</xref> Patients undergoing endovascular techniques had overall lower costs, shorter length of stay, and lower complications rates. The mortality was not measured to be significantly different between the endovascular group (1.8%) and open group (2.5%).<xref ref-type="bibr" rid="article-39.r13">[13]</xref>&#x000a0;There are also some cases being repaired laparoscopically, primarily in Europe.<xref ref-type="bibr" rid="article-39.r14">[14]</xref></p>
        <p>
<bold>Type A Lesions</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>CIA unilateral or bilateral stenosis;</p>
          </list-item>
          <list-item>
            <p>EIA single lesion of unilateral or bilateral &#x0003c;3cm stenosis.</p>
          </list-item>
        </list>
        <p>
<bold>Type B Lesions</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Stenosis less than 3m involving&#x000a0;the infrarenal aorta</p>
          </list-item>
          <list-item>
            <p>CIA unilateral occlusion</p>
          </list-item>
          <list-item>
            <p>EIA with unilateral single/multiple areas of stenosis (totaling 3 to 10cm),&#x000a0;sparing CFA</p>
          </list-item>
          <list-item>
            <p>EIA with unilateral occlusion (sparing origins of IIA or CFA)</p>
          </list-item>
        </list>
        <p>
<bold>Type C Lesions</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Bilateral CIA occlusion</p>
          </list-item>
          <list-item>
            <p>Bilateral EIA&#x000a0;stenosis of 3 to 10cm, sparing CFA&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Unilateral EIA stenosis with the inclusion of ipsilateral CFA</p>
          </list-item>
          <list-item>
            <p>Unilateral EIA occlusion with the inclusion of origin of IIA and/or CFA&#x000a0;</p>
          </list-item>
          <list-item>
            <p>EIA occlusion with heavy calcification with/without associated inclusion of IIA and/or CFA</p>
          </list-item>
        </list>
        <p>
<bold>Type D Lesions</bold>
<xref ref-type="bibr" rid="article-39.r6">[6]</xref>
<xref ref-type="bibr" rid="article-39.r10">[10]</xref>
<xref ref-type="bibr" rid="article-39.r11">[11]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Occlusion of the infrarenal aortoiliac region</p>
          </list-item>
          <list-item>
            <p>Disease diffusely&#x000a0;involving the aorta and bilateral CIA</p>
          </list-item>
          <list-item>
            <p>Multiple diffuse areas of stenosis including unilateral CIA and ipsilateral EIA, CFA</p>
          </list-item>
          <list-item>
            <p>Occlusion of unilateral CIA and ipsilateral EIA</p>
          </list-item>
          <list-item>
            <p>Occlusion of Bilateral EIA&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Iliac stenosis with co-existing AAA requiring treatment, but is unamenable to endograft</p>
          </list-item>
          <list-item>
            <p>Lesions necessitating open aortic or iliac surgery</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-39.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>An absolute contraindication to aortofemoral bypass&#x000a0;includes any patient who is too unfit for general anesthesia. Some patients who are ineligible for aortofemoral bypass, are candidates to undergo axillofemoral bypass. However, the discussion of that surgery is outside the scope of this article.<xref ref-type="bibr" rid="article-39.r15">[15]</xref></p>
        <p>Relative contraindications or patients who are at increased risk of complications from having the aortofemoral bypass surgery&#x000a0;include those with significant heart disease, recent cerebrovascular accident, recent myocardial infarction, multiple previous abdominal surgeries, retroperitoneal fibrosis, or horseshoe kidney. Also, end-stage renal disease patients are a high-risk operative group.<xref ref-type="bibr" rid="article-39.r15">[15]</xref></p>
      </sec>
      <sec id="article-39.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>For the procedure, the surgeon will&#x000a0;benefit from having a&#x000a0;specialized vascular tray, which will include vascular (typically atraumatic) clamps, vessel loops, specialized needle drivers, and fine forceps (Geralds). They will also require a graft to form the bypass, which is likely to be supplied by different manufacturers at your facility. The&#x000a0;graft that is available at a given hospital is dependent on which manufacturer has privileges&#x000a0;at the hospital or operative facility. The surgeon will also require suture for the anastomosis of the graft to the native vessel. Patients will also require heparin during the procedure. Heparin administration is standard prior to clamping&#x000a0;any of the blood vessels to help prevent thrombosis. Usually,&#x000a0;protamine&#x000a0;is administered towards the end of the case&#x000a0;for the&#x000a0;reversal of the anticoagulant effect. At the end of the procedure, it is often beneficial to have various hemostatic agents readily available should they be needed.</p>
      </sec>
      <sec id="article-39.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>To perform the procedure, the surgeon will need to have adequate experience in vascular surgery (usually fellowship training) and personnel trained in recognizing and utilizing the materials necessary for the procedure.</p>
      </sec>
      <sec id="article-39.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>In preparation for the procedure, you should ask your patient to partake in<xref ref-type="bibr" rid="article-39.r16">[16]</xref>:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Tobacco cessation at&#x000a0;least 3 to 4 weeks before surgery &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Exercising</p>
          </list-item>
        </list>
        <p>&#x000a0;In addition to specific patient preparation, the surgeon should also have on hand<xref ref-type="bibr" rid="article-39.r17">[17]</xref><xref ref-type="bibr" rid="article-39.r18">[18]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Blood on call to the operating room for the patient, should it be needed, (with cell saver available)</p>
          </list-item>
        </list>
        <p>Addition, pre-operative stress testing, cardiac angiography, or&#x000a0;intervention&#x000a0;(open or percutaneously)&#x000a0;have reduced mortality for aortic operations.<xref ref-type="bibr" rid="article-39.r19">[19]</xref></p>
        <p>&#x000a0;Perioperative&#x000a0;antibiotics should be administered to help decrease surgical site wound infections.<xref ref-type="bibr" rid="article-39.r20">[20]</xref></p>
      </sec>
      <sec id="article-39.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>For an open technique, the patient positioning is supine with arms abducted to 90 degrees. The patient should undergo prepping from the nipples to the knees. The CFA, superficial, and deep femoral arteries bilaterally are isolated through bilateral groin incisions. It is essential to be sure that the distal portions of&#x000a0;the vessels are soft, so they are suitable for clamping. Aortic exposure is typically through a midline incision (transperitoneal approach); however, some prefer a retroperitoneal approach or transverse incision. The retroperitoneum is entered, typically infracolically and after the duodenum is mobilized to the right. The aorta gets dissected below the level of the renal arteries. Most try to remain to the right of the inferior mesenteric vein to avoid violation of the left mesocolon. The renal vein can be mobilized by ligation of its tributaries. Exposure of the aorta needs to be taken down to the level of the inferior mesenteric artery. Tunnels within the retroperitoneum, posterior to the ureters are carried down to the groin incisions. On the left side, the tunnel is often brought posterior to the inferior mesenteric artery to help with keeping the graft isolated from the left mesocolon.<xref ref-type="bibr" rid="article-39.r17">[17]</xref><xref ref-type="bibr" rid="article-39.r21">[21]</xref><xref ref-type="bibr" rid="article-39.r16">[16]</xref> Heparin is administered (70 to 100 units/kg) with goal ACT 250 to 300 seconds, and then the aorta is clamped below the renal arteries and on the distal portion already exposed.<xref ref-type="bibr" rid="article-39.r22">[22]</xref><xref ref-type="bibr" rid="article-39.r23">[23]</xref><xref ref-type="bibr" rid="article-39.r24">[24]</xref> The surgeon divides the aorta and a portion resected proximal to the inferior mesenteric artery. The distal aorta is oversewn. The chosen graft is anastomosed to the proximal aorta, most commonly in an end-to-end fashion using a 3-0 or 4-0 running permanent suture.</p>
        <p>The limbs of the graft are then flushed with heparinized saline, clamped and passed through the tunnels into the groin incisions. Clamps are applied to the CFA, and an arteriotomy is made, sometimes down to the level of the profunda, thus&#x000a0;requiring a profundaplasty. Endarterectomy follows, if necessary. The graft is anastomosed to the CFA in an end-to-side running manner usually with 4-0 or 5-0 permanent suture. Before completion of the anastomosis, usual backbleeding, forward bleeding and flushing are employed. The opposite femoral artery is done similarly. Blood flow is restored to the CFA, then profunda femoris, and lastly the superficial femoral artery. However, before unclamping, anesthesia should be notified because of the expected hypotension with reperfusion. The retroperitoneum should be closed in layers to adequately omit the graft from the GI tract. If unable to sufficiently close the retroperitoneum, then an omental flap should be created.<xref ref-type="bibr" rid="article-39.r17">[17]</xref><xref ref-type="bibr" rid="article-39.r21">[21]</xref><xref ref-type="bibr" rid="article-39.r16">[16]</xref><xref ref-type="bibr" rid="article-39.r25">[25]</xref></p>
        <p>The end-to-end anastomosis is preferred because it allows the graft to lie flatter and thus may lessen the chance of future aortoenteric fistula. This method also better allows for retrograde perfusion into the inferior mesenteric artery. However, in cases where there is bilateral external iliac artery occlusion, an end-to-side or formal reconstruction of one of the IIA is needed to ensure blood flow delivery to the pelvis.</p>
        <p>There are also laparoscopic approaches, but this is not a widely utilized technique at this point.<xref ref-type="bibr" rid="article-39.r21">[21]</xref> There also is a relatively new technique called the EndoVascular RetroperitoneoScopic Technique (EVREST), which is a&#x000a0;sutureless and&#x000a0;clampless technique used&#x000a0;during laparoscopic, retroperitoneal aortobifemoral&#x000a0;bypass surgery.<xref ref-type="bibr" rid="article-39.r26">[26]</xref><xref ref-type="bibr" rid="article-39.r27">[27]</xref></p>
      </sec>
      <sec id="article-39.s10" sec-type="Complications">
        <title>Complications</title>
        <p>As with any surgical procedure, there exists a risk of bleeding or infection. In addition, there is a risk of&#x000a0;wound infection, hematoma. Complications that result in significant morbidities include MI,&#x000a0;renal dysfunction, and respiratory dysfunction. Late complications include hernias, graft thrombosis, and graft pseudoaneurysms, graft infections, aortoenteric fistulas further discussed below.</p>
        <p>Most frequently, (in 50% of cases), cardiac ischemia is responsible for death related to aortic reconstruction, which is because there are seldom patients with&#x000a0;normal coronary arteries. Hence the importance of pre-operative screening and treatment and cardiac co-morbidities. Mortality related to cardiac death following surgical intervention is 1% to 2.5% in some centers.<xref ref-type="bibr" rid="article-39.r19">[19]</xref></p>
        <p>Another common complication following surgery is renal insufficiency. This condition is typically a result of prolonged ischemia after clamping suprarenal, embolization secondary to clamping, hypoperfusion, hypovolemia or intrinsic renal artery disease.&#x000a0;Often, this post-operative complication directly relates to the patient's preoperative&#x000a0;cardiac and renal function. Knowing your patient's anatomy and having a&#x000a0;precise plan preoperatively&#x000a0;for clamping help reduce the incidence of&#x000a0;renal insufficiency in the perioperative period.<xref ref-type="bibr" rid="article-39.r19">[19]</xref></p>
        <p>Graft limb thrombosis happens in&#x000a0;up to 30%&#x000a0;of patients&#x000a0;following aortobifemoral&#x000a0;bypass. A higher incidence occurs with&#x000a0;younger patients, female gender,&#x000a0;and extra-anatomic bypasses and those who failed to quit smoking post-operatively. Typically this is unilateral limb thrombosis, which most often occurs due to continuous intimal hyperplasia or outflow disease.<xref ref-type="bibr" rid="article-39.r28">[28]</xref></p>
        <p>An anastomotic pseudoaneurysm occurs in 1% to 5% of cases as a late complication.<xref ref-type="bibr" rid="article-39.r29">[29]</xref><xref ref-type="bibr" rid="article-39.r30">[30]</xref>ypically&#x000a0;pseudoaneurysms arise secondary to a weakening near the suture line and&#x000a0;maybe a sterile process or the product of infection. The most common site is at the femoral anastomosis. Typically, symptoms include a slowly enlarging bulge in the groin or are discovered incidentally on imaging. If an infection is an underlying cause, the most common causative organism is the <italic toggle="yes">Staphylococcus</italic> species. Graft infection is associated with high morbidity and mortality.<xref ref-type="bibr" rid="article-39.r31">[31]</xref> Repair is the usual recommendation if larger than 2 cm, if aortic pseudoaneurysm is greater than 50% of graft diameter, or if the graft is infected.<xref ref-type="bibr" rid="article-39.r29">[29]</xref><xref ref-type="bibr" rid="article-39.r30">[30]</xref> If the graft is infected, excision is usually indicated.</p>
        <p>Aortoenteric fistula is a relatively rare occurrence but tends to be devastating and lethal&#x000a0;if it occurs.<xref ref-type="bibr" rid="article-39.r32">[32]</xref> Mortality is at least 30% in most cases.<xref ref-type="bibr" rid="article-39.r33">[33]</xref> Typically it occurs secondary to an erosion of the proximal suture line on the aorta through the 3rd or 4th portion in the duodenum. It is often difficult to diagnosis because the triad of sepsis, abdominal pain, and GI bleeding are not always present. There may be a smaller, self-limited "herald-bleed" that occurs before any massive GI bleeding. CT scan with IV contrast and upper endoscopy are sometimes helpful in diagnosis. An important part of the patient's history will include the history of aortic surgery with graft placement. When found, emergency exploratory laparotomy is necessary with graft excision, debridement of infected tissue, bowel repair/resection, and extra-anatomic bypass or new graft placement. Even if surgery is successful, there is still high mortality associated with this complication.<xref ref-type="bibr" rid="article-39.r32">[32]</xref><xref ref-type="bibr" rid="article-39.r33">[33]</xref><xref ref-type="bibr" rid="article-39.r34">[34]</xref></p>
      </sec>
      <sec id="article-39.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>There is high post-procedure revascularization in most cases with 5-year patency typically ranging from 64 to 95%.<xref ref-type="bibr" rid="article-39.r4">[4]</xref></p>
        <p>Eighty percent of aortobifemoral bypass surgeries are successful and open the artery and relieve symptoms for approximately 10 years after the procedure. Pain is usually relieved when the patient is resting and greatly reduced when walking. The outlook is improved if the patient quits smoking prior to and after the bypass surgery.&#x000a0;<xref ref-type="bibr" rid="article-39.r35">[35]</xref><xref ref-type="bibr" rid="article-39.r3">[3]</xref></p>
      </sec>
      <sec id="article-39.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Multi-faceted approach with vascular trained physicians who are both skilled in minimally invasive procedures and open procedures would undoubtedly enhance the outcome of these patients. Also, appropriate pre-operative workup with physician evaluation from other specialties can also be necessary for improving patient outcomes in populations with co-morbid conditions (particularly, other cardiac, renal, or pulmonary co-morbidities).&#x000a0;Radiologists with experience in reading vascular studies are also crucial for helping to determine the extent of disease accurately. Anesthesia is essential intraoperatively for monitoring of blood pressure and treatment of reperfusion hypotension. Specialty-trained nurses play a vital role in post-operative management and monitoring of the patient's hemodynamic status and urine output. They should assist the interprofessional team in coordination of care, patient and family education, and monitoring of the patient's progress; reporting any untoward changes in the patient's condition to the team. All these disciplines need to collaborate to guide cases to optimal outcomes. [Level V]</p>
        <p>The TASC II (Inter-Society Consensus for the Management of Peripheral Arterial Disease) recommends that patients be evaluated to undergo endovascular intervention first, if able (Level of Evidence B, Level III). Type A &#x00026; B&#x000a0;lesions in TASC classification&#x000a0;are&#x000a0;recommended to undergo endovascular therapy (Level of Evidence C, Level V). Whereas low-risk Type D lesions and low-risk surgical patients with Type C lesions are recommended to undergo surgical intervention (Level of Evidence C, Level V).<xref ref-type="bibr" rid="article-39.r11">[11]</xref></p>
      </sec>
      <sec id="article-39.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=39&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=39">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/39/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=39">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-39.s14">
        <fig id="article-39.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Aortofemoral bypass, abdominal aorta, blockage, graft, femoral aorta Illustration by Emma Gregory</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="0-8" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-39.s15">
        <title>References</title>
        <ref id="article-39.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Brown</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Muco</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <chapter-title>Leriche Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>2</month>
            <day>13</day>
            <pub-id pub-id-type="pmid">30855836</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chiu</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Nightingale</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Bradbury</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Adam</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease.</article-title>
            <source>Eur J Vasc Endovasc Surg</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>460</fpage>
            <page-range>460-71</page-range>
            <pub-id pub-id-type="pmid">20303805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Scully</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Madenci</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Arnaoutakis</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Ozaki</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Belkin</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Thirty-year trends in aortofemoral bypass for aortoiliac occlusive disease.</article-title>
            <source>J Vasc Surg</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>68</volume>
            <issue>6</issue>
            <fpage>1796</fpage>
            <page-range>1796-1804.e2</page-range>
            <pub-id pub-id-type="pmid">30001912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Vries</surname>
                <given-names>SO</given-names>
              </name>
              <name>
                <surname>Hunink</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis.</article-title>
            <source>J Vasc Surg</source>
            <year>1997</year>
            <month>Oct</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>558</fpage>
            <page-range>558-69</page-range>
            <pub-id pub-id-type="pmid">9357455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mah&#x000e9;</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kaladji</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Le Faucheur</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jaquinandi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Internal Iliac Artery Disease Management: Still Absent in the Update to TASC II (Inter-Society Consensus for the Management of Peripheral Arterial Disease).</article-title>
            <source>J Endovasc Ther</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>233</fpage>
            <page-range>233-4</page-range>
            <pub-id pub-id-type="pmid">26763263</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wressnegger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kinstner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Funovics</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Treatment of the aorto-iliac segment in complex lower extremity arterial occlusive disease.</article-title>
            <source>J Cardiovasc Surg (Torino)</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-9</page-range>
            <pub-id pub-id-type="pmid">25475917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahmed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Raman</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Fishman</surname>
                <given-names>EK</given-names>
              </name>
            </person-group>
            <article-title>CT angiography and 3D imaging in aortoiliac occlusive disease: collateral pathways in Leriche syndrome.</article-title>
            <source>Abdom Radiol (NY)</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>42</volume>
            <issue>9</issue>
            <fpage>2346</fpage>
            <page-range>2346-2357</page-range>
            <pub-id pub-id-type="pmid">28401281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pokharel</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Regensteiner</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Spertus</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Smolderen</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Racial Heterogeneity in Treatment Effects in Peripheral Artery Disease: Insights From the CLEVER Trial (Claudication: Exercise Versus Endoluminal Revascularization).</article-title>
            <source>Circ Cardiovasc Qual Outcomes</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>e004157</fpage>
            <pub-id pub-id-type="pmid">29643064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <article-title>Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Section D: chronic critical limb ischaemia.</article-title>
            <source>Eur J Vasc Endovasc Surg</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>19 Suppl A</volume>
            <fpage>S144</fpage>
            <page-range>S144-243</page-range>
            <pub-id pub-id-type="pmid">10957907</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ratnam</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Raza</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Horton</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Markose</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Munneke</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Belli</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Outcome of aortoiliac, femoropopliteal and infrapopliteal endovascular interventions in lesions categorised by TASC classification.</article-title>
            <source>Clin Radiol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>67</volume>
            <issue>10</issue>
            <fpage>949</fpage>
            <page-range>949-54</page-range>
            <pub-id pub-id-type="pmid">22947210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Norgren</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hiatt</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Dormandy</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Nehler</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Fowkes</surname>
                <given-names>FG</given-names>
              </name>
              <collab>TASC II Working Group</collab>
            </person-group>
            <article-title>Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).</article-title>
            <source>J Vasc Surg</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>45 Suppl S</volume>
            <fpage>S5</fpage>
            <page-range>S5-67</page-range>
            <pub-id pub-id-type="pmid">17223489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bosiers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Deloose</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Callaert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Maene</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Beelen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Keirse</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Verbist</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Peeters</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schro&#x000eb;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lauwers</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lansink</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Vanslembroeck</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>D'archambeau</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Hendriks</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lauwers</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vermassen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Randon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Van Herzeele</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>De Ryck</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De Letter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lanckneus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Van Betsbrugge</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Deleersnijder</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vandekerkhof</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Baeyens</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Berghmans</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Buttiens</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Van Den Brande</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Debing</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rabbia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ruffino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tealdi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Stegher</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gasparini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Piccoli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Coppi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Silingardi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cataldi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Paroni</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Palazzo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Stella</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gargiulo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Muccini</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nessi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ferrero</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pratesi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fargion</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chiesa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marone</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bertoglio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cremonesi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dozza</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Galzerano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>De Donato</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Setacci</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>BRAVISSIMO: 12-month results from a large scale prospective trial.</article-title>
            <source>J Cardiovasc Surg (Torino)</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>235</fpage>
            <page-range>235-53</page-range>
            <pub-id pub-id-type="pmid">23558659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Indes</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Mandawat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tuggle</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Muhs</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sosa</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Endovascular procedures for aorto-iliac occlusive disease are associated with superior short-term clinical and economic outcomes compared with open surgery in the inpatient population.</article-title>
            <source>J Vasc Surg</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>1173</fpage>
            <page-range>1173-9, 1179.e1</page-range>
            <pub-id pub-id-type="pmid">20691560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bath</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rahimi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leite</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Pierre-Louis</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Giglia</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Laparoscopic aortobifemoral bypass in a USA academic center.</article-title>
            <source>J Cardiovasc Surg (Torino)</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>332</fpage>
            <page-range>332-339</page-range>
            <pub-id pub-id-type="pmid">30417632</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kogel</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>J&#x000f6;rg-Friedrich Vollmar, M.D., Professor em. of Surgery, University Ulm, mastery in vascular surgery.</article-title>
            <source>Langenbecks Arch Surg</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>395</volume>
            <issue>4</issue>
            <fpage>463</fpage>
            <page-range>463-4</page-range>
            <pub-id pub-id-type="pmid">20213462</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Obitsu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shigematsu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[Revascularization for the aortoiliac regions of peripheral arterial disease].</article-title>
            <source>Nihon Geka Gakkai Zasshi</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>111</volume>
            <issue>2</issue>
            <fpage>79</fpage>
            <page-range>79-83</page-range>
            <pub-id pub-id-type="pmid">20387585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bajardi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ricevuto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Grassi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Latteri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Proximal anastomosis in aorto-bifemoral bypass. Technical considerations].</article-title>
            <source>Minerva Chir</source>
            <year>1989</year>
            <month>May</month>
            <day>15</day>
            <volume>44</volume>
            <issue>9</issue>
            <fpage>1353</fpage>
            <page-range>1353-5</page-range>
            <pub-id pub-id-type="pmid">2761737</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kelley-Patteson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ammar</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Kelley</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Should the Cell Saver Autotransfusion Device be used routinely in all infrarenal abdominal aortic bypass operations?</article-title>
            <source>J Vasc Surg</source>
            <year>1993</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>261</fpage>
            <page-range>261-5</page-range>
            <pub-id pub-id-type="pmid">8350435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hertzer</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Bena</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Karafa</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>A personal experience with direct reconstruction and extra-anatomic bypass for aortoiliofemoral occlusive disease.</article-title>
            <source>J Vasc Surg</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>527</fpage>
            <page-range>527-535; discussion 535</page-range>
            <pub-id pub-id-type="pmid">17321340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hodgkiss-Harlow</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Bandyk</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Antibiotic therapy of aortic graft infection: treatment and prevention recommendations.</article-title>
            <source>Semin Vasc Surg</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>191</fpage>
            <page-range>191-8</page-range>
            <pub-id pub-id-type="pmid">22230673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guo</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Qi</surname>
                <given-names>LX</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>ZG</given-names>
              </name>
            </person-group>
            <article-title>Totally laparoscopic bypass surgery for aortoiliac occlusive disease in China.</article-title>
            <source>Chin Med J (Engl)</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>126</volume>
            <issue>16</issue>
            <fpage>3069</fpage>
            <page-range>3069-72</page-range>
            <pub-id pub-id-type="pmid">23981614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manny</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Romanoff</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hyam</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Manny</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Monitoring of intraoperative heparinization in vascular surgery.</article-title>
            <source>Surgery</source>
            <year>1976</year>
            <month>Nov</month>
            <volume>80</volume>
            <issue>5</issue>
            <fpage>641</fpage>
            <page-range>641-3</page-range>
            <pub-id pub-id-type="pmid">982283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tremey</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Szekely</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schlumberger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fran&#x000e7;ois</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sievert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fischler</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Anticoagulation monitoring during vascular surgery: accuracy of the Hemochron low range activated clotting time (ACT-LR).</article-title>
            <source>Br J Anaesth</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>97</volume>
            <issue>4</issue>
            <fpage>453</fpage>
            <page-range>453-9</page-range>
            <pub-id pub-id-type="pmid">16873382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Greenstein</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Kester</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Systemic heparinization during peripheral vascular surgery: thromboelastographic, activated coagulation time, and heparin titration monitoring.</article-title>
            <source>J Cardiothorac Vasc Anesth</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>150</fpage>
            <page-range>150-2</page-range>
            <pub-id pub-id-type="pmid">8204807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clair</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Beach</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Strategies for managing aortoiliac occlusions: access, treatment and outcomes.</article-title>
            <source>Expert Rev Cardiovasc Ther</source>
            <year>2015</year>
            <month>May</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>551</fpage>
            <page-range>551-63</page-range>
            <pub-id pub-id-type="pmid">25907618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Segers</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Horn</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bazi</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Lemaitre</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Van Den Broeck</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Roman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bosschaerts</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>New development for aorto bifemoral bypass--a clampless and sutureless endovascular and laparoscopic technique.</article-title>
            <source>Vascular</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>188</fpage>
            <page-range>188-92</page-range>
            <pub-id pub-id-type="pmid">23508384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Segers</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Horn</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lemaitre</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Van Den Broeck</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hizette</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bosschaerts</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Preliminary results from a prospective study of laparoscopic aortobifemoral bypass using a clampless and sutureless aortic anastomotic technique.</article-title>
            <source>Eur J Vasc Endovasc Surg</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>48</volume>
            <issue>4</issue>
            <fpage>400</fpage>
            <page-range>400-6</page-range>
            <pub-id pub-id-type="pmid">25065340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nevelsteen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Suy</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Graft occlusion following aortofemoral Dacron bypass.</article-title>
            <source>Ann Vasc Surg</source>
            <year>1991</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>32</fpage>
            <page-range>32-7</page-range>
            <pub-id pub-id-type="pmid">1825467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hagino</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Fujitani</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Mills</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Proximal anastomotic failure following infrarenal aortic reconstruction: late development of true aneurysms, pseudoaneurysms, and occlusive disease.</article-title>
            <source>Ann Vasc Surg</source>
            <year>1993</year>
            <month>Jan</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-13</page-range>
            <pub-id pub-id-type="pmid">8518123</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghansah</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Complications of major aortic and lower extremity vascular surgery.</article-title>
            <source>Semin Cardiothorac Vasc Anesth</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>335</fpage>
            <page-range>335-61</page-range>
            <pub-id pub-id-type="pmid">15583793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Connor</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Andrew</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Batt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Becquemin</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>A systematic review and meta-analysis of treatments for aortic graft infection.</article-title>
            <source>J Vasc Surg</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>38</fpage>
            <page-range>38-45</page-range>
            <pub-id pub-id-type="pmid">16828424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Armstrong</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Back</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Shames</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Bandyk</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Improved outcomes in the recent management of secondary aortoenteric fistula.</article-title>
            <source>J Vasc Surg</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>660</fpage>
            <page-range>660-6</page-range>
            <pub-id pub-id-type="pmid">16242551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marolt</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Potrc</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bergauer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arslani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Papes</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Aortoduodenal fistula three years after aortobifemoral bypass: case report and literature review.</article-title>
            <source>Acta Clin Croat</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>363</fpage>
            <page-range>363-8</page-range>
            <pub-id pub-id-type="pmid">24558769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Limani</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Place</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Philippart</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dubail</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Aortoduodenal fistula following aortobifemoral bypass.</article-title>
            <source>Acta Chir Belg</source>
            <year>2005</year>
            <month>Apr</month>
            <volume>105</volume>
            <issue>2</issue>
            <fpage>207</fpage>
            <page-range>207-9</page-range>
            <pub-id pub-id-type="pmid">15906917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-39.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amato</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fusco</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Acampora</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bontempi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rosa</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Colais</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cruciani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>D'Ovidio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mataloni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Minozzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mitrova</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Pinnarelli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Saulle</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Soldati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sorge</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vecchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ventura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Davoli</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data.</article-title>
            <source>Epidemiol Prev</source>
            <year>2017</year>
            <season>Sep-Dec</season>
            <volume>41</volume>
            <issue>5-6 (Suppl 2)</issue>
            <fpage>1</fpage>
            <page-range>1-128</page-range>
            <pub-id pub-id-type="pmid">29205995</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
